Veeva SystemsVEEV +0.22%83 3-Year ROIIC % is 32.34 as of Jan. 2026, which is 32% above its 10-year median of 24.52. GuruFocus rates VEEV with a GF Score™ of 83/100 and a GF Value™ of $288.16 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 621 Healthcare Providers & Services companies, Veeva Systems ranks better than 79.39% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Veeva Systems's 3-Year ROIIC % for the quarter that ended in Jan. 2026 was 32.34%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Veeva Systems's 3-Year ROIIC % or its related term are showing as below:
VEEV's 3-Year ROIIC % is ranked better than 79.39% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs VEEV: 32.34
Veeva Systems (NYSE:VEEV) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Veeva Systems 3-Year ROIIC % Related Terms
Veeva Systems 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Veeva Systems's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Veeva Systems's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Veeva Systems (VEEV) has a 3-Year ROIIC % of 32.34 as of Jan. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Veeva Systems and its competitors. This is 32% above median its historical median of 24.52. Over the past decade, Veeva Systems' 3-Year ROIIC % has ranged from 3.28 to 73.72. According to the industry distribution chart, Veeva Systems ranks #128 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is Veeva Systems' 3-Year ROIIC % too high?
Veeva Systems' current 3-Year ROIIC % of 32.34 is 32% above median its 10-year median of 24.52. Over the past 10 years, this metric has ranged from a low of 3.28 to a high of 73.72. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. Veeva Systems' value of 32.34 is 834.7% above this industry median. Based on the distribution chart, Veeva Systems ranks #128 out of 621 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Veeva Systems has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' 3-Year ROIIC % compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #128 out of 621 companies for 3-Year ROIIC %. This places Veeva Systems in the top 21% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.46. Veeva Systems' value of 32.34 is 834.7% above this benchmark. Historically, Veeva Systems' own 3-Year ROIIC % has ranged from 3.28 to 73.72 over the past decade. While the company's 10-year median is 24.52 vs. the industry median of 3.46, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current 3-Year ROIIC % of 32.34 is 834.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current 3-Year ROIIC % is 32.34, which is 32% above median its own 10-year median of 24.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is $288.16, compared to a current price of $190.12 — trading 34% below its estimated fair value. The current 3-Year ROIIC % is 32.34, which is 32% above median its 10-year median of 24.52 and 834.7% above the Healthcare Providers & Services industry median of 3.46. Veeva Systems' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Veeva Systems (VEEV), the current 3-Year ROIIC % is 32.34 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $190.12 is trading 34% below its estimated GF Value™ of $288.16.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for VEEV:
3-Year ROIIC %: 32.34 (32% above median its 10-year median of 24.52)
GF Value™: $288.16 vs. price of $190.12 (34% below fair value)
Industry Position: 834.7% above the Healthcare Providers & Services median (#128 of 621)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
83GF Score
Get the complete analysis for VEEV
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
